ArticleBMC pregnancy and childbirth2026
Analysis of medication adherence and influencing factors in postpartum patients with persistent hyperglycemia following gestational diabetes mellitus.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeThis retrospective cohort study aimed to investigate medication behavior and associated influencing factors among patients with gestational diabetes mellitus (GDM) who developed abnormal glucose metabolism during the postpartum period, with the goal of informing the development of a patient-centered postpartum glucose management model. PATIENTS AND
methodsWe included patients diagnosed with GDM who delivered at Nanjing Drum Tower Hospital between January 1, 2020, and December 31, 2022. Using a combination of semi-structured telephone interviews and structured questionnaires, we retrospectively collected and analyzed data related to postpartum medication behaviors and factors affecting treatment initiation.
resultsAmong the 274 participants, 80 received pharmacological intervention and 194 did not. In the pharmacotherapy group, the average interval from delivery to initiation of medication was 12.3 ± 6.6 months, with monotherapy being the most common regimen (72.5% metformin). Telephone interviews revealed generally low medication adherence and overall dissatisfaction with current postpartum glucose management. Multivariate analysis identified the following factors associated with initiation of pharmacological treatment: impaired fasting glucose combined with impaired glucose tolerance (IFG + IGT), dyslipidemia, use of hypoglycemic agents during pregnancy, and higher perceived diabetes risk (OR > 1, p < 0.05). Conversely, elevated HbA1c levels, breastfeeding beyond one year, and higher self-efficacy were associated with reduced likelihood of medication intervention (OR < 1, p < 0.05).
conclusionsPostpartum glycemic management remains suboptimal in patients with persistent hyperglycemia after GDM. Identified barriers to pharmacotherapy—including delayed initiation and misalignment with postpartum daily life—highlight the need for more adaptable and personalized management models to improve long-term medication adherence and outcomes.
trial registrationThis study has been publicly registered in the Chinese Clinical Trial Registry (ChiCTR) (registration no. ChiCTR2300074444, registration date:2023/08/07, retrospectively registered).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.